The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The company is already marketing the 4 mg and 10 mg strengths
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
The company will submit its comprehensive response on these observations to the USFDA
Subscribe To Our Newsletter & Stay Updated
